Debate: Adjuvant vs Neoadjuvant CPIs in Resectable NSCLC? - DISCUSSION

Moderator(s)

• 

  Corey J. Langer, MD, FACP

  Abramson Cancer Center, Hospital of the University of Pennsylvania

Panelist(s)

• 

  Jamie E. Chaft, MD

  Memorial Sloan Kettering Cancer Center
• 

  Joel W. Neal, MD, PhD

  Stanford University Medical Center